These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29987132)

  • 1. Considerations for development of therapies for cutaneous neurofibroma.
    Verma SK; Riccardi VM; Plotkin SR; Weinberg H; Anderson RR; Blakeley JO; Jarnagin K; Lee J
    Neurology; 2018 Jul; 91(2 Suppl 1):S21-S30. PubMed ID: 29987132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of cutaneous neurofibromas: Consensus recommendations for setting research priorities.
    Brosseau JP; Pichard DC; Legius EH; Wolkenstein P; Lavker RM; Blakeley JO; Riccardi VM; Verma SK; Brownell I; Le LQ
    Neurology; 2018 Jul; 91(2 Suppl 1):S14-S20. PubMed ID: 29987131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous neurofibromas: Current clinical and pathologic issues.
    Ortonne N; Wolkenstein P; Blakeley JO; Korf B; Plotkin SR; Riccardi VM; Miller DC; Huson S; Peltonen J; Rosenberg A; Carroll SL; Verma SK; Mautner V; Upadhyaya M; Stemmer-Rachamimov A
    Neurology; 2018 Jul; 91(2 Suppl 1):S5-S13. PubMed ID: 29987130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating a comprehensive research strategy for cutaneous neurofibromas.
    Blakeley JO; Wolkenstein P; Widemann BC; Lee J; Le LQ; Jackson R; Stathis M; Verma SK
    Neurology; 2018 Jul; 91(2 Suppl 1):S1-S4. PubMed ID: 29987129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.
    Maguiness S; Berman Y; Rubin N; Dodds M; Plotkin SR; Wong C; Moertel C;
    Neurology; 2021 Aug; 97(7 Suppl 1):S25-S31. PubMed ID: 34230204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial design for cutaneous neurofibromas.
    Cannon A; Jarnagin K; Korf B; Widemann BC; Casey D; Ko HS; Blakeley JO; Verma SK; Pichard DC
    Neurology; 2018 Jul; 91(2 Suppl 1):S31-S37. PubMed ID: 29987133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective of Adults With Neurofibromatosis 1 and Cutaneous Neurofibromas: Implications for Clinical Trials.
    Cannon A; Pichard DC; Wolters PL; Adsit S; Erickson G; Lessing AJ; Li P; Narmore W; Röhl C; Rosser T; Widemann BC; Blakeley JO; Plotkin SR;
    Neurology; 2021 Aug; 97(7 Suppl 1):S15-S24. PubMed ID: 34230202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
    Ly I; Romo CG; Gottesman S; Kelly KM; Kornacki D; York Z; Lee SY; Rhodes SD; Staedtke V; Steensma MR; Blakeley JO; Wolkenstein P
    J Invest Dermatol; 2023 Aug; 143(8):1388-1396. PubMed ID: 37294242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with neurofibromatosis type I.
    Malhotra N; Levy JMS; Fiorillo L
    Pediatr Dermatol; 2019 May; 36(3):360-361. PubMed ID: 30828862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.
    Lin MJ; Yao H; Vera K; Patel E; Johnson M; Caroline P; Ramos J; Mehta J; Hu X; Blakeley JO; Romo CG; Sarin KY
    JAMA Dermatol; 2024 Oct; 160(10):1091-1098. PubMed ID: 39196570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status and Recommendations for Incorporating Biomarkers for Cutaneous Neurofibromas Into Clinical Research.
    Wallis D; Stemmer-Rachamimov A; Adsit S; Korf B; Pichard D; Blakeley J; Sarin KY;
    Neurology; 2021 Aug; 97(7 Suppl 1):S42-S49. PubMed ID: 34230199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.
    Guiraud M; Bouroubi A; Beauchamp R; Bocquet A; Grégoire JM; Rauly-Lestienne I; Blanco I; Wolkenstein P; Schmitt AM
    Orphanet J Rare Dis; 2019 Dec; 14(1):286. PubMed ID: 31801570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
    Nguyen HTL; Kohl E; Bade J; Eng SE; Tosevska A; Al Shihabi A; Tebon PJ; Hong JJ; Dry S; Boutros PC; Panossian A; Gosline SJC; Soragni A
    Cell Rep Methods; 2024 May; 4(5):100772. PubMed ID: 38744290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
    Rhodes SD; McCormick F; Cagan RL; Bakker A; Staedtke V; Ly I; Steensma MR; Lee SY; Romo CG; Blakeley JO; Sarin KY
    J Invest Dermatol; 2023 Aug; 143(8):1358-1368. PubMed ID: 37245145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating Techniques for Measurement of Cutaneous Neurofibromas: Recommendations for Clinical Trials.
    Thalheimer RD; Merker VL; Ly KI; Champlain A; Sawaya J; Askenazi NL; Herr HP; Da JLW; Jordan JT; Muzikansky A; Pearce EM; Sakamoto FH; Blakeley JO; Anderson RR; Plotkin SR;
    Neurology; 2021 Aug; 97(7 Suppl 1):S32-S41. PubMed ID: 34230197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.
    Wang WN; Koguchi-Yoshioka H; Nimura K; Watanabe R; Tanemura A; Fujimoto M; Wataya-Kaneda M
    J Invest Dermatol; 2024 Jan; 144(1):133-141.e4. PubMed ID: 37301319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.
    Oliveira LB; Geller M; Cunha KS; Santos A; Bernacchi A; Rubenstein AE; Takirambudde S; Mezitis S; de Almeida Ito Brum C; Darrigo LG; Ribeiro MG
    Heliyon; 2021 Mar; 7(3):e06518. PubMed ID: 33817379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
    Grit JL; Turner L; Essenburg CJ; Gallik KL; Dischinger PS; Shurlow ND; Pate MJ; Graveel CR; Steensma MR
    J Invest Dermatol; 2024 Sep; 144(9):2052-2065.e8. PubMed ID: 38395106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan in intra-operative edema of NF1-associated neurofibromas.
    Hagel C; Behrens T; Prehm P; Schnabel C; Glatzel M; Friedrich RE
    Neuropathology; 2012 Aug; 32(4):406-14. PubMed ID: 22129111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and progress of cutaneous neurofibroma].
    Zhu B; Wei C; Wang W; Gu B; Li Q; Wang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Sep; 36(9):1064-1071. PubMed ID: 36111466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.